EBNA1 facilitates the degradation of the METTL3 protein via the K48-linked ubiquitin pathway, reducing TLR9 m6A modification and YTHDF1-enhanced translation, thus promoting tumor immune evasion [68] (Table 2). The gene discussed is TLR9; the disease is neoplasm.